DZD8586 in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (TAI-SHAN9)
Clinical trial NCT06539195 · COMPLETED
Trial details
- NCT number
- NCT06539195
- Sponsor
- Dizal Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-13
- Primary completion
- 2026-06-10
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.